Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-115368

EVP, Head of North America sold 80 shares at $28.00 ($2,240)

  • EVP, Head of North America acquired 80 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lee Jennifer Kayden EVP, Head of North America 2023-11-03 Option exercise 10b5-1 +80 $6.80 $544 1,727 D
Lee Jennifer Kayden EVP, Head of North America 2023-11-03 Sale 10b5-1 −80 $28.00 $2,240 1,647 D
Derivatives
Lee Jennifer Kayden EVP, Head of North America 2023-11-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −80 67,592 D
Open-market sales · 80 sh · avg $28.00 · $2,240
Loading xslF345X05/tm2330154-1_4seq1.xml…